Sylvamo
- Market cap
- 1.26B
- P/E (TTM)i
- 16.99
- P/Bi
- 1.32
- EPSi
- 3.24
- Div yieldi
- 7.08%
- 52W posi
- 2%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Fair Value how this is computed
- Implied fair-value range of 19.48-54.23, from this stock's own trailing 5-year average P/E applied to trailing EPS.
- Current price is -13.8% below the average-multiple fair value of 36.86.
Valuation each multiple against its own 5-year range
Vs. peers Paper & Paper Products
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Sylvamo (SLVM) | 1.26B | 16.99 | 1.32 | 7.08% |
| Suzano (SUZ) | 10.37B | 6.37 | 1.05 | 2.68% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 54.3% below Morningstar's fair value estimate.
Fair value
Sylvamo Corp earns a 5-star quantitative star rating, reflecting our opinion that this share class offers a compelling opportunity for investors. The stock currently trades at a 33% discount to our quantitative fair value estimate of $49.01 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The company's valuation metrics strengthen our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 73.9% lies in the top 40% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are cheap.
The company's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's earnings yield of 7.3%, a core component of profitability, lies in the top 40% compared with global peers. This suggests that it is generating substantial earnings relative to its share price, which further promotes our favorable price/fair value ratio.
Economic moat
This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-10-08 07:00:16 · For reference only, not investment advice and not tailored to your situation.